Blood Cancer Treatment Allows Hard-to-Match Kidney Failure Patients to Receive a Compatible Kidney Transplant

A novel phase 1 trial co-led by NYU Langone researchers demonstrates CAR T cell therapy can safely desensitize even the most challenging transplant candidates. NEW YORK, June 3, 2026 /PRNewswire/ -- A pioneering clinical trial has successfully enabled three patients with end-stage kidney...